{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "NAAT",
      "PCR",
      "SARS-CoV-2",
      "genome",
      "mutation",
      "quality",
      "sequence",
      "target",
      "variant"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37815347",
  "DateCompleted": {
    "Year": "2023",
    "Month": "12",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "10",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e00761-23",
      "10.1128/spectrum.00761-23"
    ],
    "Journal": {
      "ISSN": "2165-0497",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "6",
        "PubDate": {
          "Year": "2023",
          "Month": "Dec",
          "Day": "12"
        }
      },
      "Title": "Microbiology spectrum",
      "ISOAbbreviation": "Microbiol Spectr"
    },
    "ArticleTitle": "Neglected SARS-CoV-2 variants and potential concerns for molecular diagnostics: a framework for nucleic acid amplification test target site quality assurance.",
    "Pagination": {
      "StartPage": "e0076123",
      "MedlinePgn": "e0076123"
    },
    "Abstract": {
      "AbstractText": [
        "Molecular tests like polymerase chain reaction were widely used during the COVID-19 pandemic but as the pandemic evolved, so did SARS-CoV-2. This virus acquired mutations, prompting concerns that mutations could compromise molecular test results and be falsely negative. While some manufacturers may have in-house programs for monitoring mutations that could impact their assay performance, it is important to promptly report mutations in circulating viral strains that could adversely impact a diagnostic test result. However, commercial test target sites are proprietary, making independent monitoring difficult. In this study, SARS-CoV-2 test target sites were sequenced to monitor and assess mutations impact, and 29 novel mutations impacting SARS-CoV-2 detection were identified. This framework for molecular test target site quality assurance could be adapted to any molecular test, ensuring accurate diagnostic test results and disease diagnoses."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health (NSH) , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "McCracken",
        "ForeName": "Gregory R",
        "Initials": "GR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Faculty of Medicine, Dalhousie University , Halifax, Nova Scotia, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Hematopathology, Department of Pathology and Laboratory Medicine, Nova Scotia Health (NSH) , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "Gaston",
        "ForeName": "Daniel",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Nova Scotia Provincial Public Health Laboratory Network (PPHLN) , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "Pettipas",
        "ForeName": "Janice",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC) , Winnipeg, Manitoba, Canada."
          }
        ],
        "LastName": "Loder",
        "ForeName": "Allana",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC) , Winnipeg, Manitoba, Canada."
          }
        ],
        "LastName": "Majer",
        "ForeName": "Anna",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC) , Winnipeg, Manitoba, Canada."
          }
        ],
        "LastName": "Grudeski",
        "ForeName": "Elsie",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC) , Winnipeg, Manitoba, Canada."
          }
        ],
        "LastName": "Labb\u00e9",
        "ForeName": "Genevi\u00e8ve",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Sciences Program, Faculty of Sciences, Dalhousie University , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "Joy",
        "ForeName": "Bryn K",
        "Initials": "BK"
      },
      {
        "Identifier": [
          "0000-0001-8674-4358"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health (NSH) , Halifax, Nova Scotia, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Faculty of Medicine, Dalhousie University , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "Patriquin",
        "ForeName": "Glenn",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0003-0593-0357"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health (NSH) , Halifax, Nova Scotia, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Faculty of Medicine, Dalhousie University , Halifax, Nova Scotia, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine (Infectious Diseases), Faculty of Medicine, Dalhousie University , Halifax, Nova Scotia, Canada."
          }
        ],
        "LastName": "LeBlanc",
        "ForeName": "Jason J",
        "Initials": "JJ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Microbiol Spectr",
    "NlmUniqueID": "101634614",
    "ISSNLinking": "2165-0497"
  },
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Clinical Laboratory Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nucleic Acid Amplification Techniques"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}